Search Results 1651-1660 of 23535 for Lesion

1. A Study to Evaluate Yttrium-90 Therapy for Radiation Lobectomy - Mayo Clinic

   AFP > 200 and radiological evidence (arterial hypervascularity) of lesion > 2 cm does not require biopsy;; Two imaging modalities (triphasic CT, MRI ...

2. Multimodal Biomarkers to Identify a Lewy Body Disease Neurodegeneration Index - Mayo Clinic

   ... lesion. In addition, as necessitated by the risks of Magnetic Resonance Imaging (MRI), patients who have any type of implanted electrical device (such as a ...

3. A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer (MOUNTAINEER-03) - Mayo Clinic

   ... lesion is required within 35 days prior to start of study treatment. HER2+ disease as determined by a tissue based assay performed at a central laboratory ...

4. Publications - Candice W. Bolan, M.D. - Mayo Clinic

   ... lesions in prostate MRI. PLoS One. 2022; 17 (5):e0268829 Epub 2022 May 23. View PubMed; Takahashi H, Vikram R, Jimenez RE, Bolan CW, Kawashima A, Karam JA ...

5. Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma - Mayo Clinic

   Lesion previously treated within the draining lymph node echelon), with macroscopic gross resection of all disease; High risk CSCC, as defined in the ...

6. Efficacy Of Daromun Neoadjuvant Intratumoral Treatment In Clinical Stage IIIB/C Melanoma Patients

   ... lesion (≥ 10 mm in longest diameter) or with multiple injectable lesions that in aggregate have a longest diameter of ≥ 10 mm. Males or females, age ≥ 18 ...

7. PTT-936, an Alpha Kinase 1 (ALPK1) Activator, Alone or in Combination with Anti-PD-1/L1 in Patients with Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

   ... lesions;; Total bilirubin (TBIL) ≤ 1.5 x ULN;; For patients not receiving ... lesion on Papanicolaou (PAP) smear, in situ prostate cancer (with no ...

8. Phase III Study Of Rilvegostomig In Combination With Bevacizumab With Or Without Tremelimumab As First-line Treatment Of Hepatocellular Carcinoma - Mayo Clinic

   * At least one measurable target lesion * co-infected with HBV and HCV are ... lesions within 7 days prior to initiation of study treatment. Note ...

9. Study Of Lurbinectedin In Combination With Doxorubicin Versus Doxorubicin Alone As First-line Treatment In Participants With Metastatic Leiomyosarcoma - Mayo Clinic

   Prior irradiation if only one target lesion (i.e., measurable) is available, unless progression of the lesion has been confirmed. Known myopathy. History of ...

10. KTX-100 MMSET Catalytic Inhibitor that Suppresses H3K36me2 in Patients with Relapsed and Refractory Multiple Myeloma - Mayo Clinic

    ... lesion or bone lesions as the only evidence for plasma cell dyscrasia, myelodysplastic syndrome or a myeloproliferative neoplasm or light chain amyloidosis ...